Both endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) are currently common treatments for early-stage gastrointestinal cancer1,2. Injecting a submucosal injection material (SIM) into the submucosa is one of the most important steps for both the EMR and ESD procedures2,3. High submucosal elevation and maintenance of submucosal elevation are critical criteria for safely conducting EMR/ESD.
Although normal saline (NS) has been used as a SIM since the invention of endoscopic therapy4,5, sodium hyaluronate (HA) was introduced as a treatment in recent years6,7. HA became widely used in endoscopic treatments as a superior SIM due to its high performance8,9,10,11. Currently, a performance comparison between the existing SIMs was conducted, and high-performance SIMs were developed to identify another superior SIM5,12,13,14,15,16,17,18.
The ex vivo model using a porcine stomach specimen has been used to evaluate SIM performance, because the estimation of SIM performance in the human gastrointestinal tract is very difficult19,20,21,22. However, this conventional ex vivo model is extremely simple, and has the scope for improvement. Reproducing an environment closer to the human gastrointestinal mucosa will enable accurate evaluation of SIM performance.
In our previous study, we developed a new ex vivo model that can be used to evaluate the performance of various SIMs in detail by applying constant tension to the specimen's ends. We also confirmed that the proposed new ex vivo model, allows accurate SHE measurement under uniform conditions and a detailed comparison of the performances of various types of SIMs23.
In this study, we present a complete appearance of the new ex vivo model, and the detailed setup methodology of the new ex vivo model is explained in detail using videos and figures. The new ex vivo model consists of parts that are easily available and can be quickly set up. Descriptions of detailed setup methodology will contribute to the dissemination of the new model.